期刊
ONCOLOGY REPORTS
卷 27, 期 1, 页码 143-150出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/or.2011.1464
关键词
hepatocellular carcinoma; ATG7; oxaliplatin; autophagy; apoptosis
类别
资金
- Nature Science Foundation of China [30872511]
- Shanghai Science and Technology Commission [08QA14047, 10ZR1419400]
- Shanghai Charity Foundation for Cancer Research
In spite of an initially promising anti-tumor activity, oxaliplatin-based combinatorial treatments can eventually result in a tumor resistance response. In this study we aimed to understand the role of autophagy in HCC cell resistance to oxaliplatin and to discuss its potential therapeutic implication. We found that exposure to oxaliplatin induced a significant increase in LC3 lipidation and subsequent LC3 puncta formation. While the proliferation of HCC cells was inhibited upon oxaliplatin exposure, inhibition of autophagy by ATG7 interference and chloroquine pre-treatment further increased the sensitivity to chemotherapy. Meanwhile, the oxaliplatin-induced apoptotic cell death was significantly enhanced. These results suggest that autophagy may function importantly in HepG2 cell resistance to oxaliplatin. Intriguingly, the resistance could be recovered apparently by inhibition of autophagy. This also points to the potential therapy for hepatoma by perturbing autophagy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据